Search by Drug Name or NDC
NDC 00173-0901-86 Sotrovimab 62.5 mg/mL Details
Sotrovimab 62.5 mg/mL
Sotrovimab is a INTRAVENOUS INJECTION, SOLUTION, CONCENTRATE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by GlaxoSmithKline LLC. The primary component is SOTROVIMAB.
Product Information
| NDC | 00173-0901 |
|---|---|
| Product ID | 0173-0901_c9cb1c3e-09db-49c1-a7c1-bd99a61dfb51 |
| Associated GPIs | 19502080002020 |
| GCN Sequence Number | 082332 |
| GCN Sequence Number Description | sotrovimab VIAL 500MG/8ML INTRAVEN |
| HIC3 | W5D |
| HIC3 Description | ANTIVIRAL MONOCLONAL ANTIBODIES |
| GCN | 49722 |
| HICL Sequence Number | 047403 |
| HICL Sequence Number Description | SOTROVIMAB |
| Brand/Generic | Generic |
| Proprietary Name | Sotrovimab |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | sotrovimab |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION, CONCENTRATE |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 62.5 |
| Active Ingredient Units | mg/mL |
| Substance Name | SOTROVIMAB |
| Labeler Name | GlaxoSmithKline LLC |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | UNAPPROVED DRUG OTHER |
| Application Number | n/a |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00173-0901-86 (00173090186)
| NDC Package Code | 0173-0901-86 |
|---|---|
| Billing NDC | 00173090186 |
| Package | 1 VIAL in 1 CARTON (0173-0901-86) / 8 mL in 1 VIAL |
| Marketing Start Date | 2021-05-26 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |